baber/WOPTO huggingface dataset:
Patent AU-2021267203-A1 (AU)
Title: Method, apparatus, and system of a fibrillated nanocellulose material
Inventor: CHANG YIU WEN
IPC: D21H11/18
Filed: 2021-05-04
Abstract: Methods, apparatus, and system of a fibrillated nanocellulose material overcome shortcomings of prior technologies by infusing nanocellulose in a fibrillated form to enhance the properties of cellulose pulp. These properties may include, for example, the mechanical and barrier properties, i.e., tensile strength, liquid, and gas impermeability such as oxygen, carbon dioxide, and oil, may be improved substantially.lt also provides a fibrillated cellulose composite material that include properties of being a strength- enhancing agent, an oligomer, carboxylic acid, plasticizer, an antimicrobial agent, water repellant, and or a transparent composite.
Patent AU-2021268600-A1 (AU)
Title: Compositions comprising gelsolin for treating frailty
Inventor: STRANDBERG TIMO E
IPC: A61K38/17
Filed: 2021-05-03
Abstract: This invention relates to the assessment of frailty conditions and methods of using gelsolin to treat frailty conditions.
Patent AU-2021270436-A1 (AU)
Title: Monitoring vial conditions during a lyophilization process
Inventor: GARVIN CHRISTOPHER JON
IPC: F26B5/06
Filed: 2021-05-11
Abstract: A method of facilitating real-time monitoring of conditions within a vial during a lyophilization process occurring within a lyophilization chamber includes, for each of a plurality of time intervals during the lyophilization process, determining current values of temperature and pressure within the lyophilization chamber and, after each time interval, determining current values of one or more conditions within the vial. Determining the current values of the condition(s) within the vial includes applying those current values as inputs to a heat and mass transfer balance model and solving for a current value of a temperature within the vial (and possibly water removed from or remaining within the product). The method also includes causing a display device to display the current value(s) of the condition(s) within the vial to a user, and/or controlling the temperature and/or pressure within the lyophilization chamber based on the current value(s) of the condition(s) within the vial.
Patent AU-2021271134-A1 (AU)
Title: Composition for the treatment and/or prevention of marine mollusc viral infection
Inventor: MORGA BENJAMIN
IPC: A61K39/12
Filed: 2021-05-14
Abstract: The present invention concerns a composition comprising at least one non-infectious virus particle for preventing and/or treating a viral infection in a marine mollusc.
Patent AU-2021275219-A1 (AU)
Title: Electronic monitoring system with KPI-based optimization
Inventor: JONES ROBERT TODD
IPC: H04W4/021
Filed: 2021-05-20
Abstract: An electronic monitoring device and system uses a wearable monitoring device in conjunction with an associated smartphone's location services to track a person's location. Cameras or biometric sensors associated with the smartphone allow incremental responses to apparent violations by requiring the wearer to check-in using a photograph, biometric data, GPS location, and other relevant information. The system optimizes compliance by tracking KPIs and using predictive analytics to adjust compliance programs as they apply to client throughout the system.
Patent AU-2021277628-A1 (AU)
Title: Underdrain system using one-piece cell dividers
Inventor: GILBERT EMILY
IPC: B01D24/12
Filed: 2021-11-30
Abstract: The present invention is directed to a one-piece cell divider ( 500) for use in a filter underdrain 
system that supports a porous plate that supports a filter media for filtering a fluid. The one-piece 
cell divider (500) includes: a divider portion (510); a porous plate support portion (539), including a 
flange that supports the porous plate; a support member portion ( 550), including a flange that 
attaches the divider ( 500) to a base. A filter underdrain using a one-piece cell divider may include: 
at least one porous plate for supporting the filter media for filtering a fluid, the porous plate 
spanning across at least two of the dividers; the at least two dividers including: one or more one
piece cell dividers; one or more multiple-piece dividers, each multiple-piece cell divider comprising 
a divider portion and a support member, the support member being directly under the divider 
portion.
Patent AU-2021278260-A1 (AU)
Title: Method for the machine-based determination of the functional state of support rollers of a belt conveyor system, computer program and machine-readable data carrier
Inventor: ESSER PHILIPP
IPC: B65G43/02
Filed: 2021-05-21
Abstract: The present invention relates to a method for the machine-based determination of the functional state of support rollers (13) of a belt conveyor system (1) during the operation of the belt conveyor system, wherein at least one unmanned vehicle (2) having at least one imaging sensor system is provided, by means of which sensor system at least parts of the belt conveyor system can be sensed in the form of image data, and wherein image data of at least one subregion of the belt conveyor system are captured as thermal image data. In the captured image data of the belt conveyor system, at least one identification image region position, in which at least one subregion of a support roller (13) is pictured, is automatically determined. For each determined identification image region position from the image data, an analysis image region position is automatically defined in the thermal image data. In each defined analysis image region position, thermal image data are automatically analyzed and the functional state of support rollers (13) is determined.
Patent AU-2021286323-A1 (AU)
Title: Jet pump spool valve
Inventor: SAUER ROBERT
IPC: F02M37/00
Filed: 2021-12-15
Abstract: A jet valve (302) to control flow of a fluid therethrough is disclosed. The jet valve 
includes a valve body (402), a juncture (404) operatively coupled to the valve body, the 
juncture having a first fluid connection (406) fluidly coupled to a header tank (202) and a 
second connection (408) fluidly coupled to a storage tank (204), a spool (414) movably 
disposed within the valve body, the spool having an aperture (416) extending 
longitudinally therethrough, a spring (438) operatively coupled between the spool and the 
valve body, and a jet pump (422) fluidly coupled to a fuel pump (210) of the header tank 
via a bleed line (310), the jet pump disposed within the aperture, wherein operation of the 
fuel pump pressurizes the bleed line and moves the spool to a first position to (i) close a 
first fluid path (500) between the header tank and the storage tank and (ii) provide a 
second fluid path (600) between the header tank and the storage tank, the second fluid 
path through the aperture, and depressurization of the bleed line enables the spring to 
move the spool to a second position to close the second fluid path and open the first fluid 
path.
4/9 
CV).  
CN.  
cCV) 
C:) 
00 
cv)) 
C:)o 
(0 00 
CCV 
Co: 
C)N 
CN: 
cn)
Patent AU-2021338273-A1 (AU)
Title: CYP81E genes conferring herbicide tolerance
Inventor: GAINES TODD
IPC: C12N15/82
Filed: 2021-09-01
Abstract: The present disclosure relates to a plant or plant part comprising a polynucleotide encoding a CYP81E polypeptide, the expression of the polynucleotide confers to the plant or plant part tolerance to synthetic auxin herbicides, such as 2,4-D. The disclosure further provides kits for identifying herbicide resistant plants and methods for determining whether a plant is herbicide resistant.
Patent AU-2021345262-A1 (AU)
Title: Antigen-binding molecules that bind cd38 and/or cd28, and uses thereof
Inventor: DILILLO DAVID
IPC: C07K16/28
Filed: 2021-09-17
Abstract: CD38 is expressed on malignant plasma cells. CD28 is a costimulatory molecule required for T-cell activation and survival. Provided herein are novel anti-CD38 antibodies, anti-CD28 antibodies, and bispecific antibodies (bsAbs) that bind to both CD38 and CD28 and act as costimulatory agents to activate T cells via binding CD80 and/or CD86. In certain embodiments, the bispecific antigen-binding molecules of the present invention are capable of inhibiting the growth of tumors expressing CD38. The bispecific antigen-binding molecules of the invention are useful for the treatment of diseases and disorders in which an upregulated or induced CD38-targeted immune response is desired and/or therapeutically beneficial. For example, the bispecific antibodies of the invention are useful for the treatment of various cancers, including multiple myeloma, lymphoma, and leukemia.
Patent AU-2021362156-A1 (AU)
Title: Combinatorial immunotherapeutic methods and compositions for pancreatic ductal adenocarcinoma treatment
Inventor: DEPINHO RONALD
IPC: A61K35/17
Filed: 2021-10-12
Abstract: Aspects of the present disclosure are directed to immunotherapeutic methods for treating a subject having PDAC. Disclosed are methods comprising treatment with two or more immunotherapeutic agents for generating an effective immune response to PDAC. Certain aspects relate to methods comprising the use of a LAG-3 antagonist and a 41BB agonist, in some cases together with a chemokine receptor inhibitor, for the treatment of PDAC. Also disclosed are compositions comprising a LAG-3 antagonist and a 41BB agonist. In some cases the disclosed compositions further comprise a chemokine receptor inhibitor.
Patent AU-2021368594-A1 (AU)
Title: Systems and apparatus for drip rate measurement for medical fluid administration
Inventor: LEKKALA NIRANJAN
IPC: A61M5/14
Filed: 2021-10-28
Abstract: A system for measuring drip rate may include a drip chamber device comprising an elongated body including an inner surface defining a chamber, and a drip rate measurement device. The drip chamber may be fluidly coupled to a container containing an IV fluid configured to drip droplets of the IV fluid into the chamber. The drip rate measurement device may include a housing configured to be mounted to the elongated body of the drip chamber, and a load cell transducer mounted in the elongated body and extending into the chamber. The load cell transducer may be configured to measure a weight of the droplets of the IV fluid and convert the weight into an electrical signal. The drip rate measurement device may further include a controller electrically coupled to the load cell transducer to process the electrical signal and output at least one parameter associated with the IV fluid.
Patent AU-2021395337-A1 (AU)
Title: Machine for heating and agitating a liquid food substance with shutdown device
Inventor: FRENZEL PASCAL
IPC: A47J43/046
Filed: 2021-12-07
Abstract: The invention relates to a machine (1) that has: a tank (21) in which a liquid food substance, e.g. milk, is processed; a food substance agitator (4); a food substance heating surface (6); a temperature sensor (81) sensing a temperature of the heating surface (6) or of the liquid food substance; and a control unit (8) controlling an activation of the agitator (4) and of the heating surface (6). The control unit (8) is configured to deactivate the agitator (4) and the heating surface (6) by deactivating first the heating surface (6) and then later deactivating the agitator (4) at an end of a run-off time determined by the control unit (8) based on a run-off temperature that is sensed by the temperature sensor (81) after the heating surface (6) has been deactivated.
Patent AU-2022204934-A1 (AU)
Title: Method for the regulation of an installation for the geological sequestration of carbon dioxide, suitable for renewable energy supply
Inventor: LOPEZ AUDREY
IPC: E21B41/00
Filed: 2022-07-11
Abstract: I I 
ABSTRACT 
Method for the regulation of an installation for the geological sequestration of carbon 
dioxide, suitable for renewable energy supply 
The invention relates to a method for the regulation of an installation (10) for the geological 
sequestration of carbon dioxide, comprising: a structure (20); a C02 storage compartment (22), 
received in said structure; a device (24) for injecting C02 into a geological reservoir (12); an energy 
production device (26); and an energy storage device (28).  
The energy production device supplies a power that varies over time, between low, 
intermediate, and high states.  
When the power supplied is in the low state, the injection device is powered by the energy 
storage device; and when said power supplied is in the high state, the injection device is powered 
by the power generation device, to ensure a continuous injection of C02 into the geological reservoir.  
Figure for the abstract: Figure 1
1/3 
26 44 10 
29 14 
28 36 
4020 
42 34 38 
24 
12 
FIG.1
Patent AU-2022218393-A1 (AU)
Title: Ostomy collection device
Inventor: ALLEN MARCUS
IPC: A61F5/44
Filed: 2022-02-03
Abstract: A ostomy collection system and an ostomy collection device (10) including: a housing (12) formed of first and second parts, which together define a top (18), base (14) and wall (16) which enclose a collecting volume for receiving and storing waste from an ostomy appliance, the first part including the top (18) and having an inlet (30) for fluidly connecting to an outlet of an ostomy appliance so that waste from the ostomy appliance flows into the collecting volume, and the second part of the housing being disconnectable from the first part of the housing.
Patent AU-2022224852-A1 (AU)
Title: Adjustable Exercise Bar Device for Spa and Methods of Use
Inventor: HALES ERIC
IPC: A63B23/12
Filed: 2022-09-02
Abstract: OF THE DISCLOSURE 
A system and method for providing an exercise bar for a user to use for rowing or other 
exercises in the water of the spa or adjacent to the spa. The exercise bar may comprise a central 
hub, and two sides, each with a first inner tube attached to opposing side of the central hub and a 
an outer tube in telescoping connection with the inner tube, and a handgrip in connection with 
the first outer tube. A connector may be mounted to the central hub, the connector to enable the 
exercise bar to be connected to one or more resistance cables. The exercise bar may be adjustable 
from a first, shorter length for use with exercises in which a user's hands are positioned closer 
together and a second, longer length for use with exercises in which a user's hands are positioned 
father apart.
55 
72c 64a 72d 
68b 
150 
68aF 64 
64 78 
72a 72b 
75a 75b 
10 
74 
50 
FIG. 6
Patent AU-2022226323-A1 (AU)
Title: Transvalvular intraannular implant for valve repair
Inventor: SUBRAMANIAN VALAVANUR A
IPC: A61F2/24
Filed: 2022-02-04
Abstract: Mitral valve prolapse and mitral regurgitation can be treating by implanting in the mitral annulus a transvalvular implant. The transvalvular implant has a first end, a first anchoring portion located proximate the first end, a second end, a second anchoring portion located proximate the second end, and a central portion. The transvalvular implant can include a wire form curved body The transvalvular implant can include eyelets and the center of the transvalvular implant can include an opening. The central portion can be positioned so that it extends transversely across a coaptive edge formed by the closure of the mitral valve leaflets. Tricuspid regurgitation can be treated by implanting in the tricuspid annulus a transvalvular bridge. The transvalvular bridge can have a first anchoring portion and a second anchoring portion. The transvalvular bridge can positioned so that the bridge extends transversely across a coaptive edges formed by the closure of the leaflets. The transvalvular bridge can be positioned between a midpoint of the anterior annulus and straddling the commissure between the posterior annulus and the septal annulus. The transvalvular bridge can be anchored to the anterior annulus, the posterior annulus, and the septal annulus.
Patent AU-2022230056-A1 (AU)
Title: Functionalized macroparticles of mesoporous silica for protein stabilization and metal removal from a beverage
Inventor: TRIULZI GIOVANNI
IPC: C12H1/07
Filed: 2022-03-03
Abstract: The present invention relates to mesoporous silica particles functionalized with at least one group having an acidic functionality and/or at least one group having a hydrophobic functionality anchored to the silica by means of a silicon-oxygen bond. The acidic functionality is preferably an alkyl group bearing a group selected from -SO
Patent AU-2022259792-A1 (AU)
Title: Plant regulatory elements and uses thereof
Inventor: FLASINSKI STANISLAW
IPC: C12N9/10
Filed: 2022-10-27
Abstract: C:\Users\gw\AppData\Roa ig\iManagc\Work\Recent\35588374AU PLANT REGULATORY ELEMENTS AND USES THEREOF\Abstract fromparnt(23470914.1docx-27/10/2022 
ABSTRACT 
The invention provides DNA molecules and constructs, and their nucleotide sequences, 
useful for modulating gene expression in plants, and for specifying intracellular or 
extracellular localization of a gene product of interest. Transgenic plants, plant cells, plant 
parts, and seeds, comprising the DNA molecules operably linked to a heterologous 
transcribable polynucleotides are also provided.
Patent AU-2022268975-A1 (AU)
Title: Ionizable cationic lipids for rna delivery
Inventor: RAJAPPAN KUMAR
IPC: C07C55/02
Filed: 2022-05-05
Abstract: The present disclosure describes compounds of Formula (I) or a pharmaceutically acceptable salt thereof: wherein: R
Patent AU-2022278594-A1 (AU)
Title: Mechanical handling apparatus
Inventor: FERENDUROS MICHAEL
IPC: B65G1/04
Filed: 2022-05-17
Abstract: An apparatus for manipulating containers or totes, the apparatus being configured to: receive a container from a spur of a semi-automated or automated storage and retrieval system and a first position; move the container to a second position, which corresponds to a predetermined location relative to a loading frame; and to move the container into a first destination location within the loading frame. Optionally, the container may then be moved to a second destination within the loading frame.
Patent AU-2022306467-A1 (AU)
Title: Compound of the 7a,8,9,10,11,11a-hexahydro-1h,7h-pyrano[2,3-c]xanthene type, method of preparation thereof, intermediates thereof and therapeutic applications thereof
Inventor: ROUSSI FANNY
IPC: C07D493/04
Filed: 2022-07-04
Abstract: Compound of the 7a,8,9,10,11,11a-hexahydro-1H,7H-pyrano[2,3-c]xanthene type, method of preparation thereof, intermediates thereof and therapeutic applications thereof. The present invention relates to compounds of formula (I) in which R
Patent AU-2022308843-A1 (AU)
Title: Signal activatable nucleic acid complexes
Inventor: HAN SI-PING
IPC: C12N15/113
Filed: 2022-07-05
Abstract: Provided herein include conditionally activatable small interfering RNA (siRNA) complexes, components, compositions, and related methods and systems. The siRNA complex can be conditionally activated upon a complementary binding to an input nucleic acid strand through a sequence in a sensor nucleic acid strand of the nucleic acid complex. The activated nucleic acid complex can release a potent RNAi duplex formed by a core nucleic acid strand and a passenger nucleic acid strand, which can specifically inhibit a target RNA.
Patent AU-2022314642-A1 (AU)
Title: Methods for predicting and/or monitoring cancer treatment response using changes in circulating cancer associated macrophage-like cells (camls)
Inventor: ADAMS DANIEL L
IPC: G01N33/483
Filed: 2022-07-21
Abstract: Means for predicting treatment response in a subject having cancer are disclosed, where the predictions are based comparing the number and size of circulating cancer associated macrophage-like cells (CAMLs) and circulating tumor cells (CTCs) found in biological samples at baseline and after induction of therapy, such as blood, from the subject.
Patent AU-2022317820-A1 (AU)
Title: Methods and compositions for treating cancer
Inventor: KAO HENRY
IPC: C07K16/28
Filed: 2022-07-28
Abstract: This invention relates to methods and compositions for use in treating cancer in a subject by administering to the subject a bispecific antibody targeting programmed cell death protein 1 (PD-1 ) and lymphocyte activation gene-3 (LAG3).
Patent AU-2022368368-A1 (AU)
Title: Low-frequency filtering unit having pattern with high consistency and antenna array
Inventor: LI SHU
IPC: H01Q1/38
Filed: 2022-08-23
Abstract: The present invention provides a low-frequency filtering unit having a pattern with high 
consistency. The pattern of the low-frequency filtering unit has high consistency, which can solve a 
distortion problem of a pattern caused by the coupling to a high-frequency array when a low
frequency unit is arranged among the high-frequency arrays, as well as solving problems of high cost, 
large process error and poor filtering effect existing in application of existing filtering structures. The 
low-frequency filtering unit comprises a vibrator arm, a balun base, a balun feeder line and a balun 
chamber tube for arranging the balun feeder line. The vibrator arm comprises two radiation arms, one 
end of the radiation arm is vertically connected to one end of the other radiation arm to form an 
integral L-shaped right-angle structure, the balun chamber tube is arranged at the connection between 
the two radiation arms, and the wave-trap structures on the transverse radiation arm and the 
longitudinal radiation arm are symmetrically arranged with a 45°angular bisector of the L-shaped 
right-angle structure as a center line; the low-frequency filtering unit is provided with four vibrator 
arms which are symmetrically arranged in pairs around the periphery of the balun base along a 
diagonal line and form an integral cross orthogonal structure, and the vibrator arms, the balun 
chamber tube, the balun feeder line and the balun base are all made of metal conductors.  
(To be published with Fig. 1) 
11
Patent AU-2023203524-A1 (AU)
Title: Substituted heterocyclyl derivatives as cdk inhibitors
Inventor: SAMAJDAR SUSANTA
IPC: C07D231/40
Filed: 2023-06-06
Abstract: The present invention provides substituted heterocyclylderivatives of formula (I), which 
are therapeutically useful, particularly as selective transcriptional CDK inhibitors including 
CDK7, CDK9, CDK12, CDK13 and CDK18, more particularly transcriptional CDK7 inhibitors.  
5 These compounds are useful in the treatment and prevention of diseases and/or disorders 
associated with selective transcriptional CDKs in a mammal. The present invention also provides 
preparation of the compounds and pharmaceutical formulations comprising at least one of the 
substituted heterocyclyl derivatives of formula (I)or a pharmaceutically acceptable salt or a 
stereoisomer thereof.
Patent AU-2023208203-A1 (AU)
Title: Antibodies useful in cancer diagnosis
Inventor: MITNACHT-KRAUS RITA
IPC: C07K16/28
Filed: 2023-07-28
Abstract: The invention relates to antibodies directed against an epitope located within the 
C-terminal portion of CLDN6 which are useful, for example, in diagnosing 
5 cancer and/or in determining whether cancer cells express CLDN6.
Patent AU-2023214240-A1 (AU)
Title: Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosis
Inventor: VILENCHIK MARIA
IPC: G01N33/574
Filed: 2023-08-08
Abstract: COMBINATIONS FOR THE TREATMENT OF NEOPLASMS USING 
QUIESCENT CELL TARGETING AND INHIBITORS OF MITOSIS 
Abstract 
G , 
tss interval DNA synthesis 
FIG. 1 
The present invention provides compositions and methods for the treatment of 
neoplasms, in particular, by targeting of quiescent cancer cells with therapeutic agents 
in combination with other treatments effective against certain neoplastic conditions, in 
particular, anticancer treatment with therapeutic agents that are inhibitors of mitosis (a 
mitotic inhibitor).
Patent AU-2023222870-A1 (AU)
Title: Monoterpenoid/phenylpropanoid-containing compounds and methods of their making and use as herbicides
Inventor: COATS JOEL R
IPC: A01N31/02
Filed: 2023-08-30
Abstract: MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS 
AND METHODS OF THEIR MAKING AND USE AS HERBICIDES 
Abstract 
Disclosed are compounds having a monoterpenoid and/or phenylpropanoid 
moiety and methods of their making and use as pesticidal compounds, such as 
herbicides.